Company Description

Artidis is a clinical-stage company, originating from the University of Basel, that is pioneering rapid tissue analysis and therapy optimization. Through its proprietary nanotechnology platform and holistic data solution, Artidis accelerates drug discovery, tissue engineering, and personalized treatment. The company focuses its research and development efforts on enhancing patient responses to chemo, immuno, and cell therapies — shaping the future of cancer care and diagnostics.